
Ana Lucrecia Woodward
Examiner (ID: 7465, Phone: (571)272-1082 , Office: P/1765 )
| Most Active Art Unit | 1765 |
| Art Unit(s) | 1796, 1501, 1711, 1765, 1512, 1314, 1504 |
| Total Applications | 3148 |
| Issued Applications | 2104 |
| Pending Applications | 173 |
| Abandoned Applications | 906 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 42855
[patent_doc_number] => 07781436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-24
[patent_title] => 'Indol-3-y-carbonyl-piperidin and piperazin-derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/492312
[patent_app_country] => US
[patent_app_date] => 2006-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33574
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/781/07781436.pdf
[firstpage_image] =>[orig_patent_app_number] => 11492312
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/492312 | Indol-3-y-carbonyl-piperidin and piperazin-derivatives | Jul 24, 2006 | Issued |
Array
(
[id] => 5051958
[patent_doc_number] => 20070032503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Method of preparation of azaindole derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/492750
[patent_app_country] => US
[patent_app_date] => 2006-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7393
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20070032503.pdf
[firstpage_image] =>[orig_patent_app_number] => 11492750
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/492750 | Method of preparation of azaindole derivatives | Jul 24, 2006 | Issued |
Array
(
[id] => 584385
[patent_doc_number] => 07449576
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-11-11
[patent_title] => 'Substituted piperazines'
[patent_app_type] => utility
[patent_app_number] => 11/491540
[patent_app_country] => US
[patent_app_date] => 2006-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 50622
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/449/07449576.pdf
[firstpage_image] =>[orig_patent_app_number] => 11491540
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/491540 | Substituted piperazines | Jul 20, 2006 | Issued |
Array
(
[id] => 4728094
[patent_doc_number] => 20080207638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/995927
[patent_app_country] => US
[patent_app_date] => 2006-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11022
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207638.pdf
[firstpage_image] =>[orig_patent_app_number] => 11995927
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/995927 | Compounds | Jul 16, 2006 | Abandoned |
Array
(
[id] => 4960602
[patent_doc_number] => 20080275027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'Piperazinone Derivatives Useful as Histamine H3 Receptor Antagonists and/or Inverse Agonists'
[patent_app_type] => utility
[patent_app_number] => 11/995929
[patent_app_country] => US
[patent_app_date] => 2006-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18337
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20080275027.pdf
[firstpage_image] =>[orig_patent_app_number] => 11995929
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/995929 | Piperazinone Derivatives Useful as Histamine H3 Receptor Antagonists and/or Inverse Agonists | Jul 16, 2006 | Abandoned |
Array
(
[id] => 5662338
[patent_doc_number] => 20060252934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl]piperazine'
[patent_app_type] => utility
[patent_app_number] => 11/487331
[patent_app_country] => US
[patent_app_date] => 2006-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10932
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252934.pdf
[firstpage_image] =>[orig_patent_app_number] => 11487331
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/487331 | Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl]piperazine | Jul 16, 2006 | Abandoned |
Array
(
[id] => 71882
[patent_doc_number] => 07754719
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-13
[patent_title] => 'Substituted piperidine derivatives as somatostatin SST1 receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/995725
[patent_app_country] => US
[patent_app_date] => 2006-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8098
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/754/07754719.pdf
[firstpage_image] =>[orig_patent_app_number] => 11995725
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/995725 | Substituted piperidine derivatives as somatostatin SST1 receptor antagonists | Jul 12, 2006 | Issued |
Array
(
[id] => 5291017
[patent_doc_number] => 20090023747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Cysteine Protease Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/994496
[patent_app_country] => US
[patent_app_date] => 2006-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25839
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20090023747.pdf
[firstpage_image] =>[orig_patent_app_number] => 11994496
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/994496 | Cysteine Protease Inhibitors | Jul 5, 2006 | Abandoned |
Array
(
[id] => 5458731
[patent_doc_number] => 20090258883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => '1H-Indole-Pyridinecarboxamide and 1H-Indole-Piperidinecarboxamide Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/988424
[patent_app_country] => US
[patent_app_date] => 2006-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22383
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258883.pdf
[firstpage_image] =>[orig_patent_app_number] => 11988424
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/988424 | 1H-Indole-Pyridinecarboxamide and 1H-Indole-Piperidinecarboxamide Compounds | Jul 5, 2006 | Abandoned |
Array
(
[id] => 5051961
[patent_doc_number] => 20070032506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'CRYSTALLINE FORMS OF (2R-TRANS)-6-CHLORO-5[[4-[(4-FLUOROPHENYL)METHYL]-2,5-DIMETHYL-1-PIPERAZINYL]CARBONYL]-N,N, 1-TRIMETHYL-ALPHA-OXO-1H-INDOLE-3-ACETAMIDE MONOHYDROCHLORIDE'
[patent_app_type] => utility
[patent_app_number] => 11/427768
[patent_app_country] => US
[patent_app_date] => 2006-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4898
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20070032506.pdf
[firstpage_image] =>[orig_patent_app_number] => 11427768
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/427768 | CRYSTALLINE FORMS OF (2R-TRANS)-6-CHLORO-5[[4-[(4-FLUOROPHENYL)METHYL]-2,5-DIMETHYL-1-PIPERAZINYL]CARBONYL]-N,N, 1-TRIMETHYL-ALPHA-OXO-1H-INDOLE-3-ACETAMIDE MONOHYDROCHLORIDE | Jun 28, 2006 | Abandoned |
Array
(
[id] => 5142525
[patent_doc_number] => 20070004741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase'
[patent_app_type] => utility
[patent_app_number] => 11/478128
[patent_app_country] => US
[patent_app_date] => 2006-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14845
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004741.pdf
[firstpage_image] =>[orig_patent_app_number] => 11478128
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/478128 | N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase | Jun 27, 2006 | Issued |
Array
(
[id] => 5859906
[patent_doc_number] => 20060229315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => '3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/426956
[patent_app_country] => US
[patent_app_date] => 2006-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17898
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20060229315.pdf
[firstpage_image] =>[orig_patent_app_number] => 11426956
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/426956 | 3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists | Jun 27, 2006 | Abandoned |
Array
(
[id] => 7693920
[patent_doc_number] => 20070015766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Quinoline Derivatives as NK-3 and NK-2 Antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/426414
[patent_app_country] => US
[patent_app_date] => 2006-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16630
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20070015766.pdf
[firstpage_image] =>[orig_patent_app_number] => 11426414
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/426414 | Quinoline Derivatives as NK-3 and NK-2 Antagonists | Jun 25, 2006 | Abandoned |
Array
(
[id] => 5417001
[patent_doc_number] => 20090042888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'Prostaglandin endoperoxide H synthase biosynthesis inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/473633
[patent_app_country] => US
[patent_app_date] => 2006-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 134270
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20090042888.pdf
[firstpage_image] =>[orig_patent_app_number] => 11473633
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/473633 | Prostaglandin endoperoxide H synthase biosynthesis inhibitors | Jun 22, 2006 | Abandoned |
Array
(
[id] => 5835393
[patent_doc_number] => 20060247224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Melanocortin receptor ligands'
[patent_app_type] => utility
[patent_app_number] => 11/473972
[patent_app_country] => US
[patent_app_date] => 2006-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87640
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20060247224.pdf
[firstpage_image] =>[orig_patent_app_number] => 11473972
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/473972 | Melanocortin receptor ligands | Jun 22, 2006 | Abandoned |
Array
(
[id] => 314875
[patent_doc_number] => 07524845
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-28
[patent_title] => 'Azaindazole compounds and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/474132
[patent_app_country] => US
[patent_app_date] => 2006-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42117
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/524/07524845.pdf
[firstpage_image] =>[orig_patent_app_number] => 11474132
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/474132 | Azaindazole compounds and methods of use | Jun 21, 2006 | Issued |
Array
(
[id] => 5754670
[patent_doc_number] => 20060223819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Quinoline Derivatives as NK-3 Antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/425508
[patent_app_country] => US
[patent_app_date] => 2006-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24250
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20060223819.pdf
[firstpage_image] =>[orig_patent_app_number] => 11425508
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/425508 | Quinoline Derivatives as NK-3 Antagonists | Jun 20, 2006 | Abandoned |
Array
(
[id] => 5851835
[patent_doc_number] => 20060235026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/425434
[patent_app_country] => US
[patent_app_date] => 2006-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10824
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20060235026.pdf
[firstpage_image] =>[orig_patent_app_number] => 11425434
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/425434 | Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists | Jun 20, 2006 | Abandoned |
Array
(
[id] => 5859916
[patent_doc_number] => 20060229320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine'
[patent_app_type] => utility
[patent_app_number] => 11/453986
[patent_app_country] => US
[patent_app_date] => 2006-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11011
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20060229320.pdf
[firstpage_image] =>[orig_patent_app_number] => 11453986
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/453986 | Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine | Jun 15, 2006 | Abandoned |
Array
(
[id] => 5859914
[patent_doc_number] => 20060229319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Enantiomers of 1-[(4-chlorophenyl) phenylmethyl)-4-[(4-methylphenyl)sulfonyl] piperazine'
[patent_app_type] => utility
[patent_app_number] => 11/453987
[patent_app_country] => US
[patent_app_date] => 2006-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10929
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20060229319.pdf
[firstpage_image] =>[orig_patent_app_number] => 11453987
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/453987 | Enantiomers of 1-[(4-chlorophenyl) phenylmethyl)-4-[(4-methylphenyl)sulfonyl] piperazine | Jun 15, 2006 | Abandoned |